Mechanisms of Vagus Nerve Stimulation for the Treatment of Neurodevelopmental Disorders: a Focus on Microglia and Neuroinflammation

Overview

Journal Front Neurosci

Date 2025 Jan 30

PMID 39881804

Authors

Makenna Gargus

Benneth Ben-Azu

Antonia Landwehr

Jaclyn Dunn

Joseph P Errico

Marie-Eve Tremblay

Affiliations

Soon will be listed here.

Abstract

The vagus nerve (VN) is the primary parasympathetic nerve, providing two-way communication between the body and brain through a network of afferent and efferent fibers. Evidence suggests that altered VN signaling is linked to changes in the neuroimmune system, including microglia. Dysfunction of microglia, the resident innate immune cells of the brain, is associated with various neurodevelopmental disorders, including schizophrenia, attention deficit hyperactive disorder (ADHD), autism spectrum disorder (ASD), and epilepsy. While the mechanistic understanding linking the VN, microglia, and neurodevelopmental disorders remains incomplete, vagus nerve stimulation (VNS) may provide a better understanding of the VN's mechanisms and act as a possible treatment modality. In this review we examine the VN's important role in modulating the immune system through the inflammatory reflex, which involves the cholinergic anti-inflammatory pathway, which releases acetylcholine. Within the central nervous system (CNS), the direct release of acetylcholine can also be triggered by VNS. Homeostatic balance in the CNS is notably maintained by microglia. Microglia facilitate neurogenesis, oligodendrogenesis, and astrogenesis, and promote neuronal survival via trophic factor release. These cells also monitor the CNS microenvironment through a complex sensome, including groups of receptors and proteins enabling microglia to modify neuroimmune health and CNS neurochemistry. Given the limitations of pharmacological interventions for the treatment of neurodevelopmental disorders, this review seeks to explore the application of VNS as an intervention for neurodevelopmental conditions. Accordingly, we review the established mechanisms of VNS action, e.g., modulation of microglia and various neurotransmitter pathways, as well as emerging preclinical and clinical evidence supporting VNS's impact on symptoms associated with neurodevelopmental disorders, such as those related to CNS inflammation induced by infections. We also discuss the potential of adapting non-invasive VNS for the prevention and treatment of these conditions. Overall, this review is intended to increase the understanding of VN's potential for alleviating microglial dysfunction involved in schizophrenia, ADHD, ASD, and epilepsy. Additionally, we aim to reveal new concepts in the field of CNS inflammation and microglia, which could serve to understand the mechanisms of VNS in the development of new therapies for neurodevelopmental disorders.

References

Biederman J, Fried R, DiSalvo M, Storch B, Pulli A, Woodworth K . Evidence of Low Adherence to Stimulant Medication Among Children and Youths With ADHD: An Electronic Health Records Study. Psychiatr Serv. 2019; 70(10):874-880. DOI: 10.1176/appi.ps.201800515. View

Ueno M, Fujita Y, Tanaka T, Nakamura Y, Kikuta J, Ishii M . Layer V cortical neurons require microglial support for survival during postnatal development. Nat Neurosci. 2013; 16(5):543-51. DOI: 10.1038/nn.3358. View

Lampros M, Vlachos N, Zigouris A, Voulgaris S, Alexiou G . Transcutaneous Vagus Nerve Stimulation (t-VNS) and epilepsy: A systematic review of the literature. Seizure. 2021; 91:40-48. DOI: 10.1016/j.seizure.2021.05.017. View

Black B, Hunter S, Cottrell H, Dar R, Takahashi N, Ferguson B . Remotely supervised at-home delivery of taVNS for autism spectrum disorder: feasibility and initial efficacy. Front Psychiatry. 2023; 14:1238328. PMC: 10568329. DOI: 10.3389/fpsyt.2023.1238328. View

Hyvarinen P, Yrttiaho S, Lehtimaki J, Ilmoniemi R, Makitie A, Ylikoski J . Transcutaneous vagus nerve stimulation modulates tinnitus-related beta- and gamma-band activity. Ear Hear. 2014; 36(3):e76-85. DOI: 10.1097/AUD.0000000000000123. View

Zaehle T, Krauel K . Transcutaneous vagus nerve stimulation in patients with attention-deficit/hyperactivity disorder: A viable option?. Prog Brain Res. 2021; 264:171-190. DOI: 10.1016/bs.pbr.2021.03.001. View

Landau A, Dyve S, Jakobsen S, Alstrup A, Gjedde A, Doudet D . Acute Vagal Nerve Stimulation Lowers α2 Adrenoceptor Availability: Possible Mechanism of Therapeutic Action. Brain Stimul. 2015; 8(4):702-7. DOI: 10.1016/j.brs.2015.02.003. View

Li X, Wei N, Song J, Liu J, Yuan J, Song R . The global burden of schizophrenia and the impact of urbanization during 1990-2019: An analysis of the global burden of disease study 2019. Environ Res. 2023; 232:116305. DOI: 10.1016/j.envres.2023.116305. View

Hajtovic S, LoPresti M, Zhang L, Katlowitz K, Kizek D, Lam S . The role of vagus nerve stimulation in genetic etiologies of drug-resistant epilepsy: a meta-analysis. J Neurosurg Pediatr. 2022; 29(6):667-680. DOI: 10.3171/2022.1.PEDS222. View

10.

Ji T, Yang Z, Liu Q, Liao J, Yin F, Chen Y . Vagus nerve stimulation for pediatric patients with intractable epilepsy between 3 and 6 years of age: study protocol for a double-blind, randomized control trial. Trials. 2019; 20(1):44. PMC: 6332620. DOI: 10.1186/s13063-018-3087-4. View

11.

McGehee D, Heath M, Gelber S, Devay P, Role L . Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science. 1995; 269(5231):1692-6. DOI: 10.1126/science.7569895. View

12.

Bansal V, Ryu S, Lopez N, Allexan S, Krzyzaniak M, Eliceiri B . Vagal stimulation modulates inflammation through a ghrelin mediated mechanism in traumatic brain injury. Inflammation. 2011; 35(1):214-20. PMC: 3282000. DOI: 10.1007/s10753-011-9307-7. View

13.

Zhang J, Geula C, Lu C, Koziel H, Hatcher L, Roisen F . Neurotrophins regulate proliferation and survival of two microglial cell lines in vitro. Exp Neurol. 2003; 183(2):469-81. DOI: 10.1016/s0014-4886(03)00222-x. View

14.

Bravo J, Forsythe P, Chew M, Escaravage E, Savignac H, Dinan T . Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011; 108(38):16050-5. PMC: 3179073. DOI: 10.1073/pnas.1102999108. View

15.

Keute M, Wienke C, Ruhnau P, Zaehle T . Effects of transcutaneous vagus nerve stimulation (tVNS) on beta and gamma brain oscillations. Cortex. 2021; 140:222-231. DOI: 10.1016/j.cortex.2021.04.004. View

16.

Snead 3rd O . On the sacred disease: the neurochemistry of epilepsy. Int Rev Neurobiol. 1983; 24:93-180. DOI: 10.1016/s0074-7742(08)60221-4. View

17.

Rosas-Ballina M, Olofsson P, Ochani M, Valdes-Ferrer S, Levine Y, Reardon C . Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science. 2011; 334(6052):98-101. PMC: 4548937. DOI: 10.1126/science.1209985. View

18.

Miyamoto A, Wake H, Ishikawa A, Eto K, Shibata K, Murakoshi H . Microglia contact induces synapse formation in developing somatosensory cortex. Nat Commun. 2016; 7:12540. PMC: 5007295. DOI: 10.1038/ncomms12540. View

19.

Bonaz B, Sinniger V, Pellissier S . The Vagus Nerve in the Neuro-Immune Axis: Implications in the Pathology of the Gastrointestinal Tract. Front Immunol. 2017; 8:1452. PMC: 5673632. DOI: 10.3389/fimmu.2017.01452. View

20.

Hao J, Simard A, Turner G, Wu J, Whiteaker P, Lukas R . Attenuation of CNS inflammatory responses by nicotine involves α7 and non-α7 nicotinic receptors. Exp Neurol. 2010; 227(1):110-9. PMC: 3019302. DOI: 10.1016/j.expneurol.2010.09.020. View